[1] SIEGEL R L,MILLER K D,FUCHS H E,et al. Cancer Statistics,2022[J]. CA Cancer J Clin,2022,72(1):7-33.
[2] FERLAY J,COLOMBET M,SOERJOMATARAM I,et al. Cancer sta-tistics for the year 2020: an overview[J]. Int J Cancer,2021,149(4):778-789.
[3] SAGINALA K,BARSOUK A,ALURU J S,et al. Epidemiology of Bladder Cancer[J]. Med Sci (Basel),2020,8(1):15.
[4] HUANG Q,ZI H,LUO L,et al. Secular trends of morbidity and mortality of prostate,bladder,and kidney cancers in China,1990 to 2019 and their predictions to 2030[J]. BMC Cancer,2022,22(1):1164.
[5] DING X F,LUAN Y,LU S M,et al. Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy[J]. World J Urol,2021,39(7):2463-2467.
[6] FRIEDRICH V,CHOI H W. The urinary microbiome: role in bladder cancer and treatment[J]. Diagnostics (Basel),2022,12(9):2068.
[7] 中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志,2001,81(5):61-67.
[8] MILLS J T,RAPP D E,SHAW N M,et al. Effect of active versus passive void trials on time to patient discharge,urinary tract infection,and urinary retention: a randomized clinical trial[J]. World J Urol,2020,38(9):2247-2252.
[9] 王天威,杨荣,刘天遥,等. 机器人辅助腹腔镜下根治性全膀胱切除术后并发症及其危险因素分析[J]. 中华腔镜泌尿外科杂志(电子版),2020,14(1):8-11.
[10] FERREIRA M P,COGHILL A E,CHAVES C B,et al. Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer[J]. Aids,2017, 31(4):523-531.
[11] 王晓寒,杜鹏飞,屈晓东,等. 非肌层浸润性膀胱癌患者TURBT术后并发尿路感染危险因素及预测模型构建[J]. 中华医院感染学杂志,2023,33(7):1071-1075.
[12] 王哲,张敬,张潮,等. 经尿道膀胱肿瘤切除术后尿道感染病原菌及预测模型[J]. 中华医院感染学杂志,2023,33(19):2944-2948.
[13] TALLOSY S P,POLES M Z,RUTAI A,et al. The microbial composition of the initial insult can predict the prognosis of experimental sepsis[J]. Sci Rep,2021,11(1):22772.
[14] 王景雨,周春雷,王猛,等. 尿道致病性大肠杆菌毒力因子与其抗生素耐药性之间的关系[J]. 天津医科大学学报,2022,28(6):648-653.
[15] 冯丽娜,李从荣,杨勇文,等. 肠杆菌科细菌产碳青霉烯酶基因型研究[J]. 中华实验和临床感染病杂志(电子版),2018,12(4):334-340.
[16] 冯四洲,陈欣. 血液病患者多药耐药革兰氏阴性菌感染的经验性治疗策略[J]. 临床血液学杂志,2019,32(3):170-173.
[17] 胡付品,郭燕,朱德妹,等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志,2022,22(5):521-530.
[18] 谢晓娟,兰天,高晶. 医院感染患者凝固酶阴性葡萄球菌的药敏试验以及耐药基因研究[J]. 广东医学,2023,44(10):1254-1257.
[19] 胡付品,郭燕,朱德妹,等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志,2020,20(1):1-10.
[20] 全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年细菌耐药性监测报告[J]. 中国感染控制杂志,2021,20(1):15-31.
[21] MCCARTY T P,LUETHY P M,BADDLEY J W,et al. Clinical utility of antifungal susceptibility testing[J]. JAC Antimicrob Resist,2022,4(3):dlac067.
[22] 赵董强,王彦,杨雪芹,等. 2015—2019年连云港市第二人民医院感染真菌患者菌株分布及耐药性分析[J]. 现代药物与临床,2021,36(8):1723-1727.
[23] 潘小虹,郭亮生,刘利芬,等. 外阴阴道念珠菌病患者感染致病真菌的分布特点及基因型分析[J]. 中国病原生物学杂志,2022, 17(3):321-324.
[24] 马庆林,朱岩,胡艺琳,等. 2018—2022年深圳市妇幼保健院分离真菌的分布及耐药情况分析[J]. 现代药物与临床,2023,38(8):2051-2055.
[1]陈可新,郝晓东,薄志强,等.≤pT2N0M0膀胱癌根治术后近期复发的影响因素分析[J].天津医科大学学报,2017,23(04):357.
CHEN Ke-xin,HAO Xiao-dong,BO Zhi-qiang,et al.Influencing factors and prognosis of short-term relapse after radical cystectomy of primary bladder cancer(≤pT2N0M0)[J].Journal of Tianjin Medical University,2017,23(04):357.
[2]孟旭英,李珍瑾,郭剑超.组蛋白甲基转移酶EZH2抑制剂联合抗癌药物对膀胱癌细胞功能影响的研究[J].天津医科大学学报,2018,24(01):25.
MENG Xu-ying,LI Zhen-jin,GUO Jian-chao.Effect of histone methyltransferase EZH2 inhibitor combined with anticancer drugs on migration and proliferation of bladder cancer cells[J].Journal of Tianjin Medical University,2018,24(04):25.
[3]刘 莉 康家旗 综 述,刘晓强 审 校.膀胱癌外周血生物标志物研究进展[J].天津医科大学学报,2018,24(06):566.
[4]刘志飞,张志宏,邢力永,等.RRM1 mRNA与吉西他滨药物膀胱灌注治疗膀胱癌疗效的关系[J].天津医科大学学报,2019,25(01):51.
LIU Zhi-fei,ZHANG Zhi-hong,XING Li-yong,et al.The relationship between expression of RRM1 mRNA and efficacy of intravesical of gemcitabine in patients with nonmuscle-insive bladder caner[J].Journal of Tianjin Medical University,2019,25(04):51.
[5]付真睿,盛 飞,张昌文,等.SOX6在膀胱癌发生发展中的作用及相关机制[J].天津医科大学学报,2019,25(04):373.
FU Zhen-rui,SHENG Fei,ZHANG Chang-wen,et al.The characteristics of SOX6 in development of bladder cancer and relevant mechanism[J].Journal of Tianjin Medical University,2019,25(04):373.
[6]王银蕾,杨 瀚,高 杰,等.PITX2启动子甲基化及其与膀胱癌临床病理的关系[J].天津医科大学学报,2020,26(01):39.
WANG Yin-lei,YANG Han,GAO Jie,et al.Methylation of PITX2 promoter and relationship with clinical pathology of bladder cancer[J].Journal of Tianjin Medical University,2020,26(04):39.
[7]王玉杰,沈冲,高深,等.长链非编码RNA-FENDRR在膀胱癌组织中的表达及临床意义[J].天津医科大学学报,2020,26(05):445.
WANG Yu-jie,SHEN Chong,GAO Shen,et al.Expression of long non-coding RNA FENDRR in human bladder cancer tissues and Clinical significance[J].Journal of Tianjin Medical University,2020,26(04):445.
[8]朱建强,郑志文,付青峰,等.人工纳米材料在膀胱癌诊疗中的研究进展[J].天津医科大学学报,2022,28(05):563.
[9]陆益,于佳熙,梁政.氯丙嗪对膀胱癌BT-B细胞迁移功能的影响[J].天津医科大学学报,2022,28(06):621.
LU Yi,YU Jia-xi,LIANG Zheng.The effect of chlorpromazine on the migration of BT-B cellsin bladder cancer[J].Journal of Tianjin Medical University,2022,28(04):621.
[10]王景雨,周春雷,王猛,等.尿道致病性大肠杆菌毒力因子与其抗生素耐药性之间的关系[J].天津医科大学学报,2022,28(06):648.
WANG Jing-yu,ZHOU Chun-lei,WANG Meng,et al.Relationship between virulence factors of urethral pathogenic Escherichia coli(UPEC) and antibiotic resistance[J].Journal of Tianjin Medical University,2022,28(04):648.